Skip to main content
. 2010 Nov 3;300(2):R186–R200. doi: 10.1152/ajpregu.00423.2010

Table 4.

Relative mRNA expression from control and diabetic hearts

Gene/Protein mRNA (Diabetic/Control) Protein (IFM Diabetic/IFM Control)
Adenine nucleotide translocator 1 (ANT1) 1.27 0.70*
ATP5B ATP synthase F1 subunit β(ATP5B) 0.94 0.66*
ATP5a1 ATP synthase subunit α (ATP5A1) 1.03 0.82*

Myocardial mRNA expression of ANT1, ATP5B, and ATP5A1 in control and diabetic mice as compared to respective protein expression levels in IFM. Values represent cellular mRNA transcript levels and IFM protein expression in diabetic compared to control. mRNA expression was normalized to GAPDH. Values are presented as means;

*

P < 0.05 for control vs. diabetic; n = 4 for each group.

HHS Vulnerability Disclosure